Thomas F. Tropea

2 months ago | onlinelibrary.wiley.com | Hanwen Zhang |Daniel Kargilis |Thomas F. Tropea |John Robinson

Introduction Parkinson's disease (PD) is a progressive neurodegenerative disorder marked by both motor symptoms, including bradykinesia, resting tremor, and rigidity; and nonmotor symptoms, such as cognitive impairment.1 The second most common neurodegenerative disease, PD affects more than 5 million people worldwide, including 1% of the population over 60 years, with further increases projected in the future.2, 3 Hence, an urgent, unmet need is to identify specific targets for disease...